文献速递中枢神经肿瘤放疗放疗物理与技术

结合临床、影像组学与深度学习特征预测脑转移瘤立体定向放疗后的局部控制

Predicting local control of brain metastases after stereotactic radiotherapy with clinical, radiomics and deep learning features.
PubMed 文献 · Radiat Oncol · 2024-12-30

研究收集129例脑转移瘤患者放疗前脑MRI与临床数据,在伊丽莎白-特维斯特登医院伽玛刀中心提取影像组学特征并用3D ResNet获取深度学习特征,以随机森林训练四种模型并经K折交叉验证比较。联合临床、影像组学和深度学习特征的模型AUC为0.88、准确率81.66%,优于仅用临床特征或临床加深度学习特征的模型,但与临床加影像组学模型相比差异未达统计学显著。

要点

  • 联合临床、影像组学与深度学习特征的模型AUC为0.88、准确率81.66%。
  • 仅用临床特征的模型AUC为0.85、准确率75.0%。
  • 联合模型较仅临床或临床加深度学习模型提升有统计学意义,较临床加影像组学模型无统计学意义。

核心结论

  • 将影像组学与深度学习特征同临床特征整合可提高脑转移瘤立体定向放疗后局部控制的预测能力。
  • 含影像组学特征的模型始终优于仅用临床特征或临床加深度学习特征的模型。
  • 整合模型预测准确率提高显示早期结局预测的潜力,可及时调整治疗以改善患者管理。

研究设计与样本

  • 研究为在伊丽莎白-特维斯特登医院伽玛刀中心收集129例患者放疗前脑MRI与临床数据。
  • MRI参数为TR/TE 25/1.86 ms、FOV 210×210×150、翻转角30°、横断面、体素0.82×0.82×1.5 mm。
  • 影像组学特征用Python影像组学特征提取器提取,深度学习特征用3D ResNet模型获取。
  • 采用随机森林机器学习算法训练四种模型并经K折交叉验证得出平均准确率等指标。

主要发现

  • 仅用临床变量模型AUC为0.85、准确率75.0%。
  • 加影像组学特征后AUC升至0.86、准确率79.33%。
  • 加深度学习特征后AUC为0.82、准确率78.0%。
  • 联合临床、影像组学与深度学习特征的模型AUC为0.88、准确率81.66%,为最佳表现。
  • 联合模型较仅临床特征模型或临床加深度学习特征模型的预测提升有统计学意义,较临床加影像组学特征模型无统计学意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Timely identification of local failure after stereotactic radiotherapy for brain metastases allows for treatment modifications, potentially improving outcomes. While previous studies showed that adding radiomics or Deep Learning (DL) features to clinical features increased Local Control (LC) prediction accuracy, their combined potential to predict LC remains unexplored. We examined whether a model using a combination of radiomics, DL and clinical features achieves better accuracy than models using only a subset of these features. MATERIALS AND METHODS: We collected pre-treatment brain MRIs (TR/TE: 25/1.86 ms, FOV: 210 × 210 × 150, flip angle: 30°, transverse slice orientation, voxel size: 0.82 × 0.82 × 1.5 mm) and clinical data for 129 patients at the Gamma Knife Center of the Elisabeth-TweeSteden Hospital. Radiomics features were extracted using the Python radiomics feature extractor and DL features were obtained using a 3D ResNet model. A Random Forest machine learning algorithm was employed to train four models using: (1) clinical features only; (2) clinical and radiomics features; (3) clinical and DL features; and (4) clinical, radiomics, and DL features. The average accuracy and other metrics were derived using K-fold cross validation. RESULTS: The prediction model utilizing only clinical variables provided an Area Under the receiver operating characteristic Curve (AUC) of 0.85 and an accuracy of 75.0%. Adding radiomics features increased the AUC to 0.86 and accuracy to 79.33%, while adding DL features resulted in an AUC of 0.82 and accuracy of 78.0%. The best performance came from combining clinical, radiomics, and DL features, achieving an AUC of 0.88 and accuracy of 81.66%. This model's prediction improvement was statistically significant compared to models trained with clinical features alone or with the combination of clinical and DL features. However, the improvement was not statistically significant when compared to the model trained with clinical and radiomics features. CONCLUSION: Integrating radiomics and DL features with clinical characteristics improves prediction of local control after stereotactic radiotherapy for brain metastases. Models incorporating radiomics features consistently outperformed those utilizing clinical features alone or clinical and DL features. The increased prediction accuracy of our integrated model demonstrates the potential for early outcome prediction, enabling timely treatment modifications to improve patient management.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Kanakarajan H, De Baene W, Hanssens P, et al. Predicting local control of brain metastases after stereotactic radiotherapy with clinical, radiomics and deep learning features. Radiat Oncol. 2024. PMID: 39736796. doi:10.1186/s13014-024-02573-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。